Ab response | Covariate factors | Total population | Petessou | Dar-es-Salam | |||
---|---|---|---|---|---|---|---|
Estimate | p | Estimate | p | Estimate | p | ||
IgG anti-PfMSP1 | Constant | 1.240 | 1.488 | 0.172 | |||
Age | 0.018 | 0.58 | 0.069 | 0.715 | − 0.005 | 0.871 | |
Group of exposure (ref = low exposure) | − 0.443 | 0.043 | − 1.02 | 0.003 | 0.268 | 0.232 | |
Site (ref = Petessou) | − 0.823 | < 0.001 | |||||
IgG1 anti-PfMSP1 | Constant | 1.230 | 1.623 | 0.245 | |||
Age | 0.006 | 0.883 | − 0.004 | 0.943 | − 0.012 | 0.753 | |
Group of exposure (ref = low exposure) | − 0.397 | 0.107 | − 1.09 | 0.006 | 0.386 | 0.148 | |
Site (ref = Petessou) | − 0.66 | 0.008 | – | – | – | – | |
IgG3 anti-PfMSP1 | Constant | 0.951 | 0.881 | 0.081 | |||
Age | 0.057 | 0.066 | 0.081 | 0.154 | 0.027 | 0.363 | |
Group of exposure (ref = low exposure) | − 0.422 | 0.033 | − 0.653 | 0.047 | − 0.126 | 0.496 | |
Site (ref = Petessou) | − 0.895 | < 0.0001 | – | – | – | – |
Ab response | Covariate factors | Total population | Petessou | Dar-es-Salam | |||
---|---|---|---|---|---|---|---|
Estimate | p | Estimate | p | Estimate | p | ||
IgG anti-PfAMA1 | Constant | − 0.025 | 1.64 | 0.129 | |||
Age | 0.018 | 0.562 | 0.044 | 0.416 | − 0.007 | 0.813 | |
Group of exposure (ref = low exposure) | 0.196 | 0.324 | 0.222 | 0.506 | 0.211 | 0.311 | |
Site (ref = Petessou) | − 1.871 | < 0.0001 | – | – | – | – | |
IgG1 anti-PfAMA1 | Constant | 0.028 | 2.37 | 0.216 | |||
Age | 0.006 | 0.87 | 0.029 | 0.683 | − 0.008 | 0.813 | |
Group of exposure (ref = low exposure) | 0.379 | 0.125 | 0.557 | 0.201 | 0.216 | 0.366 | |
Site (ref = Petessou) | − 2.576 | < 0.0001 | – | – | – | – | |
IgG3 anti-PfAMA1 | Constant | 0.021 | 1.42 | 0.045 | |||
Age | 0.046 | 0.167 | 0.069 | 0.262 | 0.014 | 0.548 | |
Group of exposure (ref = low exposure) | − 0.279 | 0.198 | − 0.525 | 0.174 | 0.053 | 0.724 | |
Site (ref = Petessou) | − 1.462 | < 0.0001 | – | – | – | – |